| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 2.62e-04 | 749 | 25 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | Notch binding | 5.18e-04 | 27 | 25 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 6.88e-06 | 99 | 26 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 3.99e-05 | 53 | 26 | 3 | GO:0045747 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of epithelial cell apical/basal polarity | 5.24e-05 | 58 | 26 | 3 | GO:0045197 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of bipolar cell polarity | 6.72e-05 | 63 | 26 | 3 | GO:0061245 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of apical/basal cell polarity | 6.72e-05 | 63 | 26 | 3 | GO:0035088 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 6.72e-05 | 63 | 26 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 1.33e-04 | 211 | 26 | 4 | GO:0060041 | |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 1.94e-04 | 90 | 26 | 3 | GO:0060042 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.84e-04 | 257 | 26 | 4 | GO:0007163 | |
| GeneOntologyBiologicalProcess | odontogenesis of dentin-containing tooth | 3.24e-04 | 107 | 26 | 3 | GO:0042475 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 3.90e-04 | 114 | 26 | 3 | GO:0008593 | |
| GeneOntologyBiologicalProcess | segmentation | 4.87e-04 | 123 | 26 | 3 | GO:0035282 | |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 5.66e-04 | 28 | 26 | 2 | GO:0060445 | |
| GeneOntologyBiologicalProcess | odontogenesis | 8.84e-04 | 151 | 26 | 3 | GO:0042476 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 1.04e-03 | 38 | 26 | 2 | GO:0007435 | |
| GeneOntologyBiologicalProcess | epithelial tube branching involved in lung morphogenesis | 1.22e-03 | 41 | 26 | 2 | GO:0060441 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.27e-03 | 171 | 26 | 3 | GO:0048593 | |
| GeneOntologyBiologicalProcess | salivary gland development | 1.34e-03 | 43 | 26 | 2 | GO:0007431 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 1.40e-03 | 177 | 26 | 3 | GO:0030010 | |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 1.60e-03 | 47 | 26 | 2 | GO:0045494 | |
| GeneOntologyCellularComponent | subapical complex | 1.26e-05 | 5 | 24 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | laminin complex | 5.65e-05 | 10 | 24 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.14e-03 | 487 | 24 | 4 | GO:0016324 | |
| GeneOntologyCellularComponent | cell-cell junction | 4.28e-03 | 591 | 24 | 4 | GO:0005911 | |
| GeneOntologyCellularComponent | apical part of cell | 4.31e-03 | 592 | 24 | 4 | GO:0045177 | |
| Domain | EGF | 1.16e-11 | 235 | 25 | 9 | SM00181 | |
| Domain | EGF-like_dom | 1.95e-11 | 249 | 25 | 9 | IPR000742 | |
| Domain | EGF_1 | 2.42e-11 | 255 | 25 | 9 | PS00022 | |
| Domain | EGF-like_CS | 2.98e-11 | 261 | 25 | 9 | IPR013032 | |
| Domain | EGF_2 | 3.41e-11 | 265 | 25 | 9 | PS01186 | |
| Domain | EGF_Ca-bd_CS | 2.74e-09 | 97 | 25 | 6 | IPR018097 | |
| Domain | EGF_CA | 3.11e-09 | 99 | 25 | 6 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.70e-09 | 106 | 25 | 6 | IPR000152 | |
| Domain | EGF_CA | 1.10e-08 | 122 | 25 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.21e-08 | 124 | 25 | 6 | IPR001881 | |
| Domain | EGF | 1.33e-08 | 126 | 25 | 6 | PF00008 | |
| Domain | EGF_3 | 1.81e-08 | 235 | 25 | 7 | PS50026 | |
| Domain | Growth_fac_rcpt_ | 4.79e-08 | 156 | 25 | 6 | IPR009030 | |
| Domain | - | 1.50e-07 | 95 | 25 | 5 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 1.79e-07 | 38 | 25 | 4 | PS50025 | |
| Domain | ASX_HYDROXYL | 1.94e-07 | 100 | 25 | 5 | PS00010 | |
| Domain | Laminin_G_2 | 2.21e-07 | 40 | 25 | 4 | PF02210 | |
| Domain | LamG | 3.27e-07 | 44 | 25 | 4 | SM00282 | |
| Domain | ConA-like_dom | 3.57e-07 | 219 | 25 | 6 | IPR013320 | |
| Domain | Laminin_G | 1.01e-06 | 58 | 25 | 4 | IPR001791 | |
| Domain | hEGF | 6.79e-06 | 28 | 25 | 3 | PF12661 | |
| Domain | Laminin_aI | 1.72e-05 | 5 | 25 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.72e-05 | 5 | 25 | 2 | PF06008 | |
| Domain | Laminin_II | 1.72e-05 | 5 | 25 | 2 | PF06009 | |
| Domain | Laminin_domII | 1.72e-05 | 5 | 25 | 2 | IPR010307 | |
| Domain | LAMININ_IVA | 4.79e-05 | 8 | 25 | 2 | PS51115 | |
| Domain | Laminin_B | 4.79e-05 | 8 | 25 | 2 | PF00052 | |
| Domain | LamB | 4.79e-05 | 8 | 25 | 2 | SM00281 | |
| Domain | Laminin_IV | 4.79e-05 | 8 | 25 | 2 | IPR000034 | |
| Domain | EGF_CA | 2.01e-04 | 86 | 25 | 3 | PF07645 | |
| Domain | LAMININ_NTER | 2.04e-04 | 16 | 25 | 2 | PS51117 | |
| Domain | Laminin_N | 2.04e-04 | 16 | 25 | 2 | PF00055 | |
| Domain | Laminin_N | 2.04e-04 | 16 | 25 | 2 | IPR008211 | |
| Domain | LamNT | 2.04e-04 | 16 | 25 | 2 | SM00136 | |
| Domain | EGF_LAM_2 | 7.31e-04 | 30 | 25 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 7.31e-04 | 30 | 25 | 2 | PS01248 | |
| Domain | Laminin_EGF | 9.96e-04 | 35 | 25 | 2 | PF00053 | |
| Domain | EGF_Lam | 9.96e-04 | 35 | 25 | 2 | SM00180 | |
| Domain | Laminin_EGF | 1.17e-03 | 38 | 25 | 2 | IPR002049 | |
| Domain | SUSHI | 2.53e-03 | 56 | 25 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 2.62e-03 | 57 | 25 | 2 | IPR000436 | |
| Domain | Galactose-bd-like | 6.97e-03 | 94 | 25 | 2 | IPR008979 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 5.78e-05 | 11 | 15 | 2 | M158 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.52e-04 | 30 | 15 | 2 | M27216 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.52e-04 | 30 | 15 | 2 | M27772 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 5.47e-04 | 33 | 15 | 2 | M39503 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 8.46e-04 | 41 | 15 | 2 | M27778 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.06e-03 | 46 | 15 | 2 | M239 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.75e-03 | 59 | 15 | 2 | M27218 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.18e-03 | 66 | 15 | 2 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.18e-03 | 66 | 15 | 2 | M18 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.88e-03 | 76 | 15 | 2 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.11e-03 | 79 | 15 | 2 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.50e-03 | 84 | 15 | 2 | M7098 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.50e-03 | 84 | 15 | 2 | M3228 | |
| Pubmed | Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. | 3.70e-09 | 5 | 26 | 3 | 29856955 | |
| Pubmed | Crumbs proteins regulate layered retinal vascular development required for vision. | 5.37e-07 | 2 | 26 | 2 | 31718797 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 30076417 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 30956116 | ||
| Pubmed | Human CRB1 and CRB2 form homo- and heteromeric protein complexes in the retina. | 5.37e-07 | 2 | 26 | 2 | 38570189 | |
| Pubmed | CRB2 acts as a modifying factor of CRB1-related retinal dystrophies in mice. | 5.37e-07 | 2 | 26 | 2 | 24565864 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 29893966 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 28544784 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 39284539 | ||
| Pubmed | The laminin response in inflammatory bowel disease: protection or malignancy? | 5.37e-07 | 2 | 26 | 2 | 25347196 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 20019771 | ||
| Pubmed | Targeted ablation of CRB1 and CRB2 in retinal progenitor cells mimics Leber congenital amaurosis. | 5.37e-07 | 2 | 26 | 2 | 24339791 | |
| Pubmed | 5.66e-07 | 22 | 26 | 3 | 28334989 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 31145883 | ||
| Pubmed | α1- and α5-containing laminins regulate the development of bile ducts via β1 integrin signals. | 1.61e-06 | 3 | 26 | 2 | 22761447 | |
| Pubmed | CRB2 Loss in Rod Photoreceptors Is Associated with Progressive Loss of Retinal Contrast Sensitivity. | 1.61e-06 | 3 | 26 | 2 | 31438467 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 9049978 | ||
| Pubmed | Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences. | 1.61e-06 | 3 | 26 | 2 | 9006922 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 24324803 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 10620696 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 17988153 | ||
| Pubmed | Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. | 1.61e-06 | 3 | 26 | 2 | 12393739 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 17699809 | ||
| Pubmed | Laminin-1 reexpression in Alport mouse glomerular basement membranes. | 3.22e-06 | 4 | 26 | 2 | 12631063 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9299121 | ||
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 3.22e-06 | 4 | 26 | 2 | 32330268 | |
| Pubmed | Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques. | 3.22e-06 | 4 | 26 | 2 | 12820173 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 29561261 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 11969289 | ||
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 5.37e-06 | 5 | 26 | 2 | 29856954 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 9719032 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 12743034 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 11829758 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 10964500 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 5.37e-06 | 5 | 26 | 2 | 9415429 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 5.37e-06 | 5 | 26 | 2 | 9389447 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 31937556 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 15668394 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 9597096 | ||
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 14557481 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 1.13e-05 | 7 | 26 | 2 | 9390664 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 16885194 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 19633172 | ||
| Pubmed | Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. | 1.50e-05 | 8 | 26 | 2 | 10102687 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 8872465 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 29155075 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 19651211 | ||
| Pubmed | FERM protein EPB41L5 is a novel member of the mammalian CRB-MPP5 polarity complex. | 1.50e-05 | 8 | 26 | 2 | 17920587 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 1.50e-05 | 8 | 26 | 2 | 9489770 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 9852162 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 32439764 | ||
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 10880400 | ||
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 9882526 | ||
| Pubmed | 1.93e-05 | 9 | 26 | 2 | 15102706 | ||
| Pubmed | Laminin γ1 C-terminal Glu to Gln mutation induces early postimplantation lethality. | 1.93e-05 | 9 | 26 | 2 | 30456378 | |
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 2.41e-05 | 10 | 26 | 2 | 16554364 | |
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 22911783 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 2.41e-05 | 10 | 26 | 2 | 16100707 | |
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 2.41e-05 | 10 | 26 | 2 | 18590826 | |
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 11784026 | ||
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 2.41e-05 | 10 | 26 | 2 | 20976766 | |
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 9034910 | ||
| Pubmed | 2.94e-05 | 11 | 26 | 2 | 12051813 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 2.94e-05 | 11 | 26 | 2 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 2.94e-05 | 11 | 26 | 2 | 23472759 | |
| Pubmed | 3.53e-05 | 12 | 26 | 2 | 9396756 | ||
| Pubmed | 3.53e-05 | 12 | 26 | 2 | 11381080 | ||
| Pubmed | 3.53e-05 | 12 | 26 | 2 | 10433923 | ||
| Pubmed | 3.53e-05 | 12 | 26 | 2 | 16750824 | ||
| Pubmed | 4.17e-05 | 13 | 26 | 2 | 36350252 | ||
| Pubmed | 4.17e-05 | 13 | 26 | 2 | 12682087 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 4.17e-05 | 13 | 26 | 2 | 21900571 | |
| Pubmed | 4.86e-05 | 14 | 26 | 2 | 9151674 | ||
| Pubmed | 4.86e-05 | 14 | 26 | 2 | 19783738 | ||
| Pubmed | 5.61e-05 | 15 | 26 | 2 | 10625553 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 5.61e-05 | 15 | 26 | 2 | 12921739 | |
| Pubmed | 5.61e-05 | 15 | 26 | 2 | 9264260 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 5.61e-05 | 15 | 26 | 2 | 15895400 | |
| Pubmed | Efficient and fast targeted production of murine models based on ENU mutagenesis. | 5.61e-05 | 15 | 26 | 2 | 16075367 | |
| Pubmed | 6.41e-05 | 16 | 26 | 2 | 30579834 | ||
| Pubmed | 6.41e-05 | 16 | 26 | 2 | 19733164 | ||
| Pubmed | 6.41e-05 | 16 | 26 | 2 | 17601529 | ||
| Pubmed | Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. | 6.41e-05 | 16 | 26 | 2 | 17229764 | |
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 7.26e-05 | 17 | 26 | 2 | 15056720 | |
| Pubmed | 7.26e-05 | 17 | 26 | 2 | 21983115 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 8.16e-05 | 18 | 26 | 2 | 39040056 | |
| Pubmed | 8.16e-05 | 18 | 26 | 2 | 11311202 | ||
| Pubmed | 8.16e-05 | 18 | 26 | 2 | 29113990 | ||
| Pubmed | 8.16e-05 | 18 | 26 | 2 | 14730302 | ||
| Pubmed | Transcriptional fates of human-specific segmental duplications in brain. | 9.12e-05 | 19 | 26 | 2 | 30228200 | |
| Pubmed | 9.12e-05 | 19 | 26 | 2 | 22398208 | ||
| Pubmed | 9.12e-05 | 19 | 26 | 2 | 17507402 | ||
| Pubmed | Yap/Taz are required for establishing the cerebellar radial glia scaffold and proper foliation. | 9.12e-05 | 19 | 26 | 2 | 31586559 | |
| Pubmed | Crumbs 2 prevents cortical abnormalities in mouse dorsal telencephalon. | 1.01e-04 | 20 | 26 | 2 | 26802325 | |
| Pubmed | 1.01e-04 | 20 | 26 | 2 | 22911573 | ||
| Pubmed | 1.01e-04 | 20 | 26 | 2 | 27616714 | ||
| Pubmed | 1.23e-04 | 22 | 26 | 2 | 35245678 | ||
| Pubmed | 1.23e-04 | 22 | 26 | 2 | 15496443 | ||
| Pubmed | Crumbs2 promotes cell ingression during the epithelial-to-mesenchymal transition at gastrulation. | 1.23e-04 | 22 | 26 | 2 | 27870829 | |
| Pubmed | A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. | 1.23e-04 | 22 | 26 | 2 | 21980299 | |
| Cytoband | 6q27 | 4.50e-04 | 55 | 26 | 2 | 6q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q27 | 9.48e-04 | 80 | 26 | 2 | chr6q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 2.78e-03 | 138 | 26 | 2 | chr9q33 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 2.98e-05 | 9 | 17 | 2 | 1223 | |
| GeneFamily | Laminin subunits | 5.46e-05 | 12 | 17 | 2 | 626 | |
| Coexpression | GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP | 3.67e-05 | 200 | 25 | 4 | M10026 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_200 | 6.99e-06 | 32 | 25 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_200 | 2.77e-05 | 151 | 25 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_200 | 3.64e-05 | 162 | 25 | 4 | gudmap_developingKidney_e15.5_S-shaped body_200 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 8.36e-05 | 951 | 25 | 7 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_500 | 9.66e-05 | 406 | 25 | 5 | gudmap_developingKidney_e15.5_S-shaped body_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_100 | 1.03e-04 | 78 | 25 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 1.05e-04 | 986 | 25 | 7 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.31e-04 | 433 | 25 | 5 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_100 | 2.25e-04 | 19 | 25 | 2 | gudmap_developingKidney_e14.5 whole kidney - wildtype_100_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_500 | 2.50e-04 | 105 | 25 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | 2.89e-04 | 811 | 25 | 6 | gudmap_developingKidney_e15.5_S-shaped body_1000 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-06 | 183 | 26 | 4 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-06 | 187 | 26 | 4 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Early_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.11e-06 | 188 | 26 | 4 | 6151051c027c7ff7d5d4bf5f1e11d7fe58eb22ed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-06 | 190 | 26 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.37e-06 | 191 | 26 | 4 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-06 | 193 | 26 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-06 | 193 | 26 | 4 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.25e-06 | 200 | 26 | 4 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 160 | 26 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 160 | 26 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-04 | 175 | 26 | 3 | f5451c29c487b998778e50349b3d774d5e20fd28 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-04 | 176 | 26 | 3 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-04 | 177 | 26 | 3 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 178 | 26 | 3 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.56e-04 | 181 | 26 | 3 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 182 | 26 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.61e-04 | 183 | 26 | 3 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-04 | 183 | 26 | 3 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 183 | 26 | 3 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 185 | 26 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 186 | 26 | 3 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.69e-04 | 186 | 26 | 3 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 186 | 26 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 187 | 26 | 3 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 188 | 26 | 3 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | EC-Sinusoidal_ECs|World / Lineage and Cell class | 1.77e-04 | 189 | 26 | 3 | 9a0956c8a7069ba3bd0fa56d052d6e514453e578 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 190 | 26 | 3 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.82e-04 | 191 | 26 | 3 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 191 | 26 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | EC|World / Lineage and Cell class | 1.85e-04 | 192 | 26 | 3 | 478866dd5b0d6ff3a76d07a17c4b5989dd7a27bb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-04 | 193 | 26 | 3 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-04 | 193 | 26 | 3 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | e164f6403a8b541ced08a6feec915d2e855036ea | |
| ToppCell | facs-MAT-Fat-3m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | b32533afeff1905e188becaa09079e9699722e4b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-04 | 193 | 26 | 3 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | 2ff573ba2c74583ed1cb071a3bbc01bb71117e5f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-04 | 195 | 26 | 3 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.94e-04 | 195 | 26 | 3 | 9016a44b521214546a55a822ebdef5b5312206d2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-04 | 196 | 26 | 3 | 46d665de09f8164690b9a3e0acf0b0afa3f81b3d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 197 | 26 | 3 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.00e-04 | 197 | 26 | 3 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.00e-04 | 197 | 26 | 3 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-04 | 198 | 26 | 3 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-04 | 198 | 26 | 3 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-04 | 198 | 26 | 3 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.06e-04 | 199 | 26 | 3 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 199 | 26 | 3 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 199 | 26 | 3 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 199 | 26 | 3 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.06e-04 | 199 | 26 | 3 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 199 | 26 | 3 | b877c1d24357249781032e99d4237f72789cc9b8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-04 | 199 | 26 | 3 | e32fa66f3361474088ba1dd58574822537950d59 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-04 | 199 | 26 | 3 | 66b4ff23b2e83fb7e6a37fdafdef315cfa33d327 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-04 | 200 | 26 | 3 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-04 | 200 | 26 | 3 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.09e-04 | 200 | 26 | 3 | d276062545ecc428a28b12a74f06f3c6bbcff4a3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-04 | 200 | 26 | 3 | 0e1f9e1622e5a0fd814a1e100f79cbca2e0dbfbb | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Mesothelial-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.09e-04 | 200 | 26 | 3 | b33901d91b3af5c0cf310eede30ce03af90c9783 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | (5)_Fibroblast-H|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.09e-04 | 200 | 26 | 3 | 94e77a1082ade6fad93a37168e037af8aefe7ff4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-04 | 200 | 26 | 3 | 671e731977c58a0c44c36b56422085d93d999aad | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.09e-04 | 200 | 26 | 3 | c082bc21ec7c5323439d108ea8aea510e1113c3f | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.09e-04 | 200 | 26 | 3 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.09e-04 | 200 | 26 | 3 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.09e-04 | 200 | 26 | 3 | 23bc13983f6bdf95e63109b8bc14c4921ca85c3a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-04 | 200 | 26 | 3 | d64895354218ebd0217011bae0967a6883bbd1cd | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.09e-04 | 200 | 26 | 3 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Tshz2-Syt2_(Layer_5a,_Entorhinal_cortex,_Tshz1+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.02e-04 | 51 | 26 | 2 | adc73d6909d75ad432aef884dae540b7e48cecd6 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.03e-04 | 57 | 26 | 2 | 9614fe2acc6ee039383504f94bbe6d35aac27f25 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.03e-04 | 57 | 26 | 2 | 3c55a5598a7ea789500f2fbd35c79d2b97a3fc7d | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gata3_(Periacqueductal_gray_(PAG)_(or_adjacent_APTD))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.03e-04 | 57 | 26 | 2 | 309b3d48bfe215d7b581722c06d444b5b2ef6a30 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.36e-04 | 69 | 26 | 2 | 54e5ede00ce2920158d1cc0ac8e718aa24a4342e | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.36e-04 | 69 | 26 | 2 | c93a47ee777b560f69b705d5d597f3cb3a3f558a | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.36e-04 | 69 | 26 | 2 | 8946d7e433c232c56563a6c464152c0a8cdbdf92 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Dlk1_(Zona_Incerta,_ventral_part_(ZIV)_and/or_Lateral_hypothalamus_(LH))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.23e-04 | 73 | 26 | 2 | cfb3d5bbb1d2b6d228c2cfbdc14e6f70860fe1f2 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Calb2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.23e-04 | 73 | 26 | 2 | 8e8d06bd4404fe6fda753e7adedc2f2150524750 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Dlk1_(Zona_Incerta,_ventral_part_(ZIV)_and/or_Lateral_hypothalamus_(LH))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.23e-04 | 73 | 26 | 2 | 23e4ed235e75c7cf2807bd0dda56be7744d0fca0 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Dlk1_(Zona_Incerta,_ventral_part_(ZIV)_and/or_Lateral_hypothalamus_(LH))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.23e-04 | 73 | 26 | 2 | 93f1a39aeb4859c2d7c821ce0ebafb7b7a9d81d4 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Calb2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.23e-04 | 73 | 26 | 2 | 48a499fa03d736310d09b01c8889db5288e9b2da | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus,_TRN+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.91e-04 | 76 | 26 | 2 | 14350e0e8fc43531f33f6ed4e583e94a13d1dde5 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.91e-04 | 76 | 26 | 2 | 492cdcbc577a9334af8e4ded469da17bc7e79025 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus,_TRN+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.91e-04 | 76 | 26 | 2 | 539f0076d0571be049c35541a3b281f86ddbecd6 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 82 | 26 | 2 | 15bc417aaace2b1d680904a622fe76e95083c9ff | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 82 | 26 | 2 | 697e1da3095c8483b8181b290fa5417bdc9cee54 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trh_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 82 | 26 | 2 | 73349906bcc8d1a40dc03df7a490a963e85564f2 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-03 | 122 | 26 | 2 | 8f675dc341b3f6e22f7e52c34d167d9e37df0982 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-03 | 122 | 26 | 2 | c7e81504e62d132624ec15b7d38dc5b6493a37a4 | |
| ToppCell | droplet-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-03 | 125 | 26 | 2 | 5a309ce803d2b8efd791eb21808121bf5fc3ea8e | |
| Drug | penam | 2.42e-05 | 7 | 25 | 2 | CID009548842 | |
| Drug | S-2-aminoethyl-L-cysteine | 2.42e-05 | 7 | 25 | 2 | CID000020049 | |
| Drug | AC1L1E5Z | 4.15e-05 | 9 | 25 | 2 | CID000002655 | |
| Drug | AC1L1G72 | 6.33e-05 | 11 | 25 | 2 | CID000003553 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.02e-04 | 27 | 23 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | neuroimaging measurement, brain volume measurement | 1.38e-03 | 286 | 23 | 3 | EFO_0004346, EFO_0006930 | |
| Disease | Intellectual Disability | 4.88e-03 | 447 | 23 | 3 | C3714756 | |
| Disease | epilepsy (implicated_via_orthology) | 7.11e-03 | 163 | 23 | 2 | DOID:1826 (implicated_via_orthology) | |
| Disease | COVID-19, mortality | 7.71e-03 | 170 | 23 | 2 | EFO_0004352, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALCAYFRPRAHDGGE | 481 | Q6UXG8 | |
| GYSCHCRLGFRPAED | 291 | Q9HCU0 | |
| FFGDRCRFLHDVGRY | 136 | Q96G46 | |
| DGDLFCARCFREGHD | 436 | Q96K21 | |
| EGFLGEYCQHRDPCE | 16 | Q7Z3S9 | |
| LADRYECHCPLGYAG | 126 | Q5IJ48 | |
| FEGATCDRCAPGYFH | 566 | O15230 | |
| FNCIDEPSRCYFHDG | 981 | Q13219 | |
| EGFLGEYCQHRDPCE | 16 | P0DPK4 | |
| VHDRLDRYCCGFEPE | 431 | Q9UFP1 | |
| FCRPRDDAFGHFTCG | 191 | O00548 | |
| EECGFLLHFRDGCYH | 176 | Q9NQT6 | |
| CPAGYAGRFCEIDHD | 136 | P82279 | |
| HFDFYCGTCVLLGRP | 76 | Q96LM9 | |
| LRADGFGDNPFYHCL | 41 | Q96F10 | |
| LEDFAFRGCPHVLGY | 126 | Q96C34 | |
| FSLGYCDFDLRPCHE | 221 | Q8WV92 | |
| DHDFRCDACLLGYEG | 1471 | P25391 | |
| CGLGYDFSRCRHEPC | 461 | Q13621 | |
| HYLDAVRDGCPGLCF | 756 | Q9UKZ4 | |
| GFYLHRGRCFDECPD | 116 | Q6UXX9 | |
| DRCFRCGEEGHLSPY | 351 | Q9NUD5 | |
| ERPYRCAFCGAGFGR | 426 | A6NFI3 | |
| CGRFAACGAEDRHAY | 766 | A2RRH5 | |
| PYLCGECGEDFSEHR | 536 | O95125 | |
| RDYGFLPELGHDCRA | 336 | O15399 |